Fermion Oy Fermion Oy

X

Digital content for NLS Pharmaceutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
NLS Pharmaceutics
Switzerland Flag
Country
Country
Switzerland
Address
Address
The Circle 6 | P.O. Box CH - 8058 Zurich
Telephone
Telephone
+41 44 512 21 50
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.accesswire.com/viewarticle.aspx?id=875778&lang=en

ACCESSWIRE
12 Jun 2024

https://www.accesswire.com/867511/nls-pharmaceutics-reports-positive-results-from-study-ko-874-on-mazindols-neuroprotective-effects-in-narcoleptic-like-rat-model

ACCESSWIRE
28 May 2024

https://www.accesswire.com/867022/nls-pharmaceutics-announces-receipt-of-additional-staff-delisting-determination-from-nasdaq

ACCESSWIRE
24 May 2024

https://www.accesswire.com/854998/nls-pharmaceutics-announces-receipt-of-staff-delisting-determination-from-nasdaq-intends-to-request-hearing

ACCESSWIRE
19 Apr 2024

https://www.accesswire.com/845956/nls-pharmaceutics-announces-closing-of-175-million-registered-direct-offering

ACCESSWIRE
22 Mar 2024

https://www.accesswire.com/845070/nls-pharmaceutics-announces-175-million-registered-direct-offering

ACCESSWIRE
20 Mar 2024

https://www.accesswire.com/844901/nls-pharmaceutics-secures-exclusive-global-license-for-next-generation-non-sulfonamide-dual-orexin-agonist-platform

ACCESSWIRE
20 Mar 2024

https://www.accesswire.com/843004/nls-pharmaceutics-to-participate-in-the-bio-europe-springtime-partnering-event

ACCESSWIRE
14 Mar 2024

https://www.accesswire.com/841568/nasdaq-accepts-nls-pharmaceutics-plan-to-regain-listing-compliance

ACCESSWIRE
11 Mar 2024

https://www.accesswire.com/viewarticle.aspx?id=836022&lang=en

ACCESSWIRE
23 Feb 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY